China investigates GSK executives for bribery, tax violations

BEIJING, July 11 (Xinhua) -- Some senior executives of multinational pharmaceutical company GlaxoSmithKline (China) Investment Co. Ltd (GSK) have been placed under criminal investigation for suspected bribery and tax-related violations, Chinese police said Thursday.

Police have questioned some of the suspects, according to a statement issued by the Ministry of Public Security.

The company is suspected of offering bribes to government officials, medical associations, hospitals and doctors in its operations in China, the statement said.

It is also suspected of being involved in some tax-related crimes, according to the ministry.

The statement said police have obtained evidence regarding the suspected offenses.

We Recommend:
How did Chinese solar industry go bankrupt?	Born to lead: 2nd gen of Chinese tycoons	Chinese graduates’ unconventional jobs
China's largest railway terminal officially opens	Dazzling gems shine at Beijing jewelry show	Boeing 787 Dreamliner to serve Beijing-Haikou route
New high-speed rail linking Nanjing, Ningbo opens	Jiaxing-Shaoxing Sea Bridge in E China	Chinese investors' happiness and sadness